Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -0.453% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) COc1cccc(CCC(=O)N(C)C2CCCN(Cc3ccccc3F)C2)c1
b.) CCOc1ccccc1NC(=O)c1cc(-c2ccccn2)nc2ccccc12
c.) COc1ccc(OC)c(S(=O)(=O)N(C)CC(=O)Nc2ccc3c(c2)OCO3)c1
Answer: a. COc1cccc(CCC(=O)N(C)C2CCCN(Cc3ccccc3F)C2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(CCC(=O)N(C)C2CCCN(Cc3ccccc3F)C2)c1
COc1cccc(CCC(=O)N(C)C2CCCN(Cc3ccccc3F)C2)c1
N-[1-[(2-fluorophenyl)methyl]piperidin-3-yl]-3-(5-methoxyphenyl)-N-methylpropanamide